ロード中...
Oral antiviral therapies for chronic hepatitis C infection
The treatment of hepatitis C virus (HCV) infection with pegylated interferon alpha and ribavirin leads to a sustained virologic response in around 50% of patients with HCV genotype 1, 65% with HCV genotype 4, 75% with HCV genotype 3 and around 80% with HCV genotype 2. A better understanding of the H...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4040722/ https://ncbi.nlm.nih.gov/pubmed/25165547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2049936113488359 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|